Katharina Dr. Schreeb
Head Of Auto Immune And Oncology @ Sangamo Therapeutics
About Katharina Dr. Schreeb
Dr. Katharina Schreeb serves as the Head of Auto Immune and Oncology at Sangamo Therapeutics, Inc., bringing extensive experience in drug development and regulatory interactions. Her previous roles include senior positions at BioNTech AG and Boehringer Ingelheim, where she contributed significantly to oncology and immune-oncology projects.